Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.
about
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceCancer stem cells and drug resistance: the potential of nanomedicineThe Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaA High Throughput Micro-Chamber Array Device for Single Cell Clonal Cultivation and Tumor Heterogeneity AnalysisThe neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.More than markers: biological significance of cancer stem cell-defining molecules.Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinomaTrefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.Cellular senescence and protein degradation: breaking down cancerNew promising drug targets in cancer- and metastasis-initiating cells.Clinical implications of cancer stem cell biology in hepatocellular carcinoma.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma.Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulationG protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinomaInhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).Sorting and identification of side population cells in the human cervical cancer cell line HeLa.Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer.Differential remodeling of extracellular matrices by breast cancer initiating cells.Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinomaElimination of cancer stem-like "side population" cells in hepatoma cell lines by chinese herbal mixture "tien-hsien liquid"An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinomaSox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancerCyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cellsHospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cellsABCG2: the key to chemoresistance in cancer stem cells?Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.The molecular pathogenesis and clinical implications of hepatocellular carcinoma.Liver regenerative medicine: advances and challenges.The emerging role of the phosphatidylinositol 3-kinase/ akt/mammalian target of rapamycin signaling network in cancer stem cell biology.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
P2860
Q26865927-09EC8B5E-329E-45A3-8DB7-53BA20D5562EQ26998993-58970DF5-418C-4434-B592-2685916CF0C7Q28071619-98AF6725-B5CA-4B47-A77B-E4CA8C3D4A08Q28079138-234D2469-948C-4D8B-98DC-EC46DEC69F75Q30656891-60B502C5-452A-4E28-ACD0-45E0A582921DQ33566593-15194743-EF43-4D93-B409-E33CCB5F5DC6Q33661278-5CBEBC63-24CC-4F93-A48A-383997C80189Q33688897-4B9B2A4F-A598-44FC-BF1D-294510F51738Q33820610-B8A1F5FF-BD3C-49E0-B386-35534ED77A50Q33850043-4EE553B8-0C5C-4BA3-ADC8-731DEE30FBFEQ33889185-F5CC2574-EAF5-4DD5-BF24-DED421C94138Q33953067-F355BD11-03A8-4B19-AF2F-5AF305AA8DF8Q34003691-19659935-F611-48B1-BCBA-5FF79A69D5AAQ34357073-5E1038C3-2F4D-49AA-896E-F85857F104C6Q34382586-8B4AFE02-9E19-43A7-8E9B-45E4481D3BCFQ34478227-9D8D28B2-4A6E-4F37-9B49-B17B901C6417Q34493986-322F72C3-2D8B-41C2-A278-27885A4D52C1Q34674548-E0A942BF-4C9F-43A3-8E33-061C3D063578Q34786517-3B44EEFB-7611-47CF-9E01-D6D8B52D665FQ34795591-D2BB513E-E5A5-4CD3-8777-3C80B0F2617EQ35085052-0E7DA492-8A50-47AA-83A1-CE7E478AE9ABQ35085092-43980DB1-1870-4D14-933F-AC04983FF25BQ35535977-E065A33C-5AFA-4706-B99E-11BE27DA5B07Q35544277-E140C9A7-8924-4C23-8317-4BFC2CDE681DQ36327378-5DC5D848-78E7-4667-9F23-CBDD93B0D825Q36336720-528333B7-0992-4038-8474-69A7742B68A7Q36413135-E2B4AF7C-772A-4CCF-8AF3-B416BA89C453Q36732896-EC08276E-5C91-4641-A195-9FAAEDF309A5Q36975824-E9EE152B-0A7A-4DCC-B6CC-3C24638A7AE2Q37209426-D1F3C107-17AC-4539-9C0F-5866F0F60703Q37520579-C6A5C647-69D0-4E50-B4D9-F4D039D47364Q37587219-78F9314D-80E4-4DA8-8A97-1FD8AB33F583Q37610799-3EDCC96B-6132-4FDE-AE62-49D8859D86D0Q37630384-3472C7BA-0238-4BD0-8F75-7BB3316A4CB0Q37821305-8E92B226-2942-4147-AB9A-A63A36F4B558Q37958162-1DA222F1-8177-4CF9-BF7D-0AE8117B455CQ37970351-324075C9-410D-4E99-9CA4-437860DAE1D2Q38008810-C2C8CE57-8300-4D51-A622-8FB71F56DDD6Q38166578-050668FB-AB5B-40E6-8D9E-D2CB9D1295C0Q38324456-AA36A1C1-1C25-4F8D-9484-A5F5DA06370C
P2860
Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@ast
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@en
type
label
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@ast
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@en
prefLabel
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@ast
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@en
P2093
P356
P1433
P1476
Analysis of ABCG2 expression a ...... s modulation by Akt signaling.
@en
P2093
Jianren Gu
Shengyong Yin
Shusen Zheng
Xiangfang Hao
P304
P356
10.1093/CARCIN/BGN223
P407
P577
2008-09-26T00:00:00Z